| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V4498 | BMS 433771 | 543700-68-1 | BMS 433771 is a novel and potent inhibitor of RSV (respiratory syncytial virus) replication in vitro. |
|
V4492 | Fosdagrocorat | 1044535-58-1 | Fosdagrocorat (formerly known as PF-04171327) is a phosphate ester prodrug of PF-00251802 (dagrocorat), a selective high-affinity partial agonist of the glucocorticoid receptor, which is further metabolized to PF-04015475. |
|
V5310 | Lanraplenib (GS-9876) | 1800046-95-0 | Lanraplenib (also known as GS-9876; GS-SYK) is a highly selective and orally bioavailable Spleen Tyrosine Kinase (SYK) inhibitor with IC50of 9.5 nM). |
|
V5289 | NE10790 (3-PEHPC) | 152831-36-2 | NE10790, an analog of risedronate, is a poor farnesyl pyrophosphate synthase inhibitor and a weak antiresorptive agent. |
|
V4479 | PF-06795071 | 2075629-81-9 | PF-06795071 is a novel, potent, selective and covalentMAGL (Monoacylglycerol lipase)inhibitor with anIC50of 3 nM and with en excellent CNS exposure. |
|
V5204 | Seco Rapamycin sodium (Secorapamycin A monosodium) | 148554-65-8 | Seco Rapamycin sodium (Secorapamycin A monosodium), the sodium salt of the ring-opened product of Rapamycin, is reported not to affect the mTOR function. |
|
V5013 | THZ1-R | 1621523-07-6 | THZ1-R is a novel and non-cysteine reactive analog of THZ1 which shows lower activity for CDK7 inhibition with a Kdof 142 nM for binding to CDK7. |
|
V5201 | UNC4976 | UNC4976 is a significantly improved cellularly efficacious chemical probe of CBX7. | |
|
V5213 | Lesraurtinib (CEP701; KT5555) | 111358-88-4 | Lestaurtinib (CEP-701; KT-5555; SP-924) is a novel,orally bioavailable and potent multi-kinase inhibitor with anticancer and anti-inflammatory activity. |